The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides.
Abstract
We examined the dose-related effects of angiotensin-converting enzyme inhibitors on circulating and tissue levels of angiotensin and bradykinin peptides by administering perindopril or lisinopril to rats in drinking water for 7 days. A reduction in the ratio of plasma angiotensin II (Ang II) to Ang I was seen for 0.006 mg/kg per day perindopril, with an increase in plasma renin and Ang I at 0.017 mg/kg per day. Plasma Ang II levels did not decrease until 1.4 mg/kg per day perindopril, at which dose plasma Ang I levels reached a plateau of an approximate 25-fold increase. The effects of perindopril on Ang II and Ang I levels in heart, lung, aorta, and brown adipose tissue were parallel to those observed for plasma. By contrast, renal Ang I levels did not increase, and renal Ang II levels decreased by 40% at 0.017 mg/kg per day, the same threshold seen for the increase in plasma renin. Perindopril increased circulating bradykinin-(1-9) levels approximately eightfold, with a threshold dose of 0.052 mg/kg per day, and increased bradykinin-(1-9) levels in kidney, heart, and lung in parallel with the changes observed for plasma. By contrast, aortic and brown adipose tissue bradykinin-(1-9) and bradykinin-(1-7) levels increased severalfold for perindopril doses as low as 0.006 mg/kg per day. Lisinopril also increased aortic bradykinin-(1-9) and bradykinin-(1-7) levels at doses below the threshold for the decrease in the ratio of Ang II to Ang I. These data indicate that renal Ang II levels and vascular bradykinin-(1-9) levels respond to low doses of converting enzyme inhibitor and may be important mediators of the effects of these compounds. The parallel increases in bradykinin-(1-9) and bradykinin-(1-7) levels in aorta and brown adipose tissue, at inhibitor doses below the threshold for inhibition of Ang I conversion, may result from a mechanism different from inhibition of "classic" angiotensin-converting enzyme.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ondetti, M. A., Rubin, B., & Cushman, D. W. (1977) · Science · doi:10.1126/science.191908 · Cited by 1,856
Inhibitors of Angiotensin-Converting Enzyme Prevent Myointimal Proliferation After Vascular Injury
Powell, J. S., Clozel, J.-P., Müller, R. K. M., Kuhn, H., Hefti, F., Hosang, M., & Baumgartner, H. R. (1989) · Science · doi:10.1126/science.2526370 · Cited by 1,052
Reid, I. A., Morris, B. J., & Ganong, W. F. (1978) · Annual Review of Physiology · doi:10.1146/annurev.ph.40.030178.002113 · Cited by 953
Urata, H., Kinoshita, A., Misono, K. S., Bumpus, F. M., & Husain, A. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45712-2 · Cited by 880
Captopril-induced Changes in Prostaglandin Production
Swartz, S. L., Williams, G. H., Hollenberg, N. K., Levine, L., Dluhy, R. G., & Moore, T. J. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109788 · Cited by 333
Jaspard, E., Wei, L., & Alhenc-Gelas, F. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98378-x · Cited by 325
Differential regulation of angiotensin peptide levels in plasma and kidney of the rat.
Campbell, D. J., Lawrence, A. C., Towrie, A., Kladis, A., & Valentijn, A. J. (1991) · Hypertension · doi:10.1161/01.hyp.18.6.763 · Cited by 242
Self-citationLinz, W., & Schölkens, B. A. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb09054.x · Cited by 236
Moore, T. J., Crantz, F. R., Hollenberg, N. K., Koletsky, R. J., Leboff, M. S., Swartz, S. L., Levine, L., Podolsky, S., Dluhy, R. G., & Williams, G. H. (1981) · Hypertension · doi:10.1161/01.hyp.3.2.168 · Cited by 214
Determinants of angiotensin II generation during converting enzyme inhibition.
Juillerat, L., Nussberger, J., Ménard, J., Mooser, V, Christen, Y., Waeber, B., Graf, P., & Brunner, H. R. (1990) · Hypertension · doi:10.1161/01.hyp.16.5.564 · Cited by 212
Wei, L., Alhenc-Gelas, F., Soubrier, F., Michaud, A., Corvol, P., & Clauser, E. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)67628-3 · Cited by 194
Johnston, C. I., Mcgrath, B. P., Millar, J. A., & Matthews, P. G. (1979) · The Lancet · doi:10.1016/s0140-6736(79)91552-6 · Cited by 188
Nephrectomy, converting enzyme inhibition, and angiotensin peptides.
Campbell, D. J., Kladis, A., & Duncan, A. M. (1993) · Hypertension · doi:10.1161/01.hyp.22.4.513 · Cited by 180
Self-citationEvidence for a Putatively New Angiotensin II-generating Enzyme in the Vascular Wall
Okunishi, H., Miyazaki, M., & Toda, N. (1984) · Journal of Hypertension · doi:10.1097/00004872-198406000-00010 · Cited by 178
Reactive Hyperreninemia Is a Major Determinant of Plasma Angiotensin II During ACE Inhibition
Mooser, V., Nussberger, J., Juillerat, L., Burnier, M., Waeber, B., Bidiville, J., Pauly, N., & Brunner, H. R. (1990) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199002000-00015 · Cited by 170
Role of kinins in the acute antihypertensive effect of the converting enzyme inhibitor, captopril.
Carretero, O. A., Miyazaki, S., & Scicli, A. G. (1981) · Hypertension · doi:10.1161/01.hyp.3.1.18 · Cited by 158
Bradykinin peptides in kidney, blood, and other tissues of the rat.
Campbell, D. J., Kladis, A., & Duncan, A.-M. (1993) · Hypertension · doi:10.1161/01.hyp.21.2.155 · Cited by 152
Self-citationKinins mediate the antiproliferative effect of ramipril in rat carotid artery
Farhy, R. D., Ho, K., Carretero, O. A., & Scicli, A. G. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)80142-1 · Cited by 139
Vasodepressor role of endogenous bradykinin assessed by a bradykinin antagonist.
Benetos, A., Gavras, H., Stewart, J. M., Vavrek, R. J., Hatinoglou, S., & Gavras, I. (1986) · Hypertension · doi:10.1161/01.hyp.8.11.971 · Cited by 115
Schölkens, B. A., Linz, W., & König, W. (1988) · Journal of Hypertension · doi:10.1097/00004872-198812040-00004 · Cited by 109
Chronic kinin receptor blockade attenuates the antihypertensive effect of ramipril.
Bao, G., Gohlke, P., Qadri, F., & Unger, T. (1992) · Hypertension · doi:10.1161/01.hyp.20.1.74 · Cited by 108
Lawrence, A. C., Evin, G. M., Kladis, A., & Campbell, D. J. (1990) · Journal of Hypertension · doi:10.1097/00004872-199008000-00005 · Cited by 98
Self-citationFenoy, F. J., Scicli, G. M., Carretero, O. A., & Roman, R. J. (1991) · Hypertension · doi:10.1161/01.hyp.17.6.1038 · Cited by 87
Unger, T., Moursi, M., Ganten, D., Hermann, K., & Lang, R. E. (1986) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198603000-00009 · Cited by 82
Effects of antihypertensive treatment in one–clip, two kidney hypertension in rats
Michel, J., Dussaule, J., Choudat, L., Auzan, C., Nochy, D., Corvol, P. L., & Ménard, J. (1986) · Kidney International · doi:10.1038/ki.1986.101 · Cited by 73
Gohlke, P., Lamberty, V., Kuwer, I., Bartenbach, S., Schnell, A., Linz, W., Schölkens, B. A., Wiemer, G., & Unger, T. (1993) · Hypertension · doi:10.1161/01.hyp.22.5.682 · Cited by 71
Inhibition by converting enzyme inhibitors of pig kidney aminopeptidase P.
Hooper, N. M., Hryszko, J., Oppong, S. Y., & Turner, A. J. (1992) · Hypertension · doi:10.1161/01.hyp.19.3.281 · Cited by 62
Peripheral hemodynamic effects of captopril in patients with congestive heart failure
Nishimura, H., Kubo, S., Ueyama, M., Kubota, J., & Kawamura, K. (1989) · American Heart Journal · doi:10.1016/0002-8703(89)90662-5 · Cited by 60
Kinin contribution to renal vasodilator effect of captopril in rabbit.
Hajj-Ali, A. F., & Zimmerman, B. G. (1991) · Hypertension · doi:10.1161/01.hyp.17.4.504 · Cited by 57
Converting enzyme inhibition in kinin-deficient brown Norway rats.
Danckwardt, L., Shimizu, I., Bönner, G., Rettig, R., & Unger, T. (1990) · Hypertension · doi:10.1161/01.hyp.16.4.429 · Cited by 57
Unger, T., Gohlke, P., & Gruber, M.-G. (1990) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-74209-5_10 · Cited by 46
Hr, C., Nielsen, H. K., Christensen, K. L., Baandrup, U. T., Jespersen, L. T., & Mulvany, M. J. (1988) · PubMed · Cited by 34
Mookherjee, S., Anderson, G. H., Eich, R. H., Hill, N. E., Smulyan, H., Streeten, D. H. P., Vardan, S., & Warner, R. A. (1983) · American Heart Journal · doi:10.1016/0002-8703(83)90286-7 · Cited by 23
Presence of High Affinity Receptor for Interleukin-1 (IL-1) on Cultured Porcine Thyroid Cells
Kasai, K., Hiraiwa, M., Emoto, T., Kuroda, H., Hattori, Y., Mochizuki, Y., Nakamura, T., & Shimoda, S.-I. (1990) · Hormone and Metabolic Research · doi:10.1055/s-2007-1004855 · Cited by 21
SEINO, M., Abe, K., Nushiro, N., Omata, K., Kasai, Y., & YOSHINAGA, K. (1988) · Journal of Hypertension · doi:10.1097/00004872-198811000-00004 · Cited by 20
ACE inhibitor effect on bradykinin metabolism in the vascular wall.
Gohlke, P., Bünning, P., Bönner, G., et al. (1992) · PubMed · Cited by 7
Cited by
Liu, Y. H., Yang, X. P., Sharov, V. G., Nass, O., Sabbah, H. N., Peterson, E., & Carretero, O. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119360 · Cited by 603
Counterregulatory Actions of Angiotensin-(1-7)
Ferrario, C. M., Chappell, M. C., Tallant, E. A., Brosnihan, K. B., & Diz, D. I. (1997) · Hypertension · doi:10.1161/01.hyp.30.3.535 · Cited by 509
Renoprotective benefits of RAS inhibition: From ACEI to angiotensin II antagonists
Taal, M. W., & Brenner, B. M. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00031.x · Cited by 439
The adipose-tissue renin–angiotensin–aldosterone system: role in the metabolic syndrome?
Engeli, S., Schling, P., Gorzelniak, K., Boschmann, M., Janke, J., Ailhaud, G., Teboul, M., Massiéra, F., & Sharma, A. M. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00311-4 · Cited by 415
Angiotensin-(1-7) Dilates Canine Coronary Arteries Through Kinins and Nitric Oxide
Brosnihan, K. B., Li, P., & Ferrario, C. M. (1996) · Hypertension · doi:10.1161/01.hyp.27.3.523 · Cited by 404
Metadata
- Authors
- Campbell, D. J., Kladis, A., & Duncan, A. M.
- Venue
- Hypertension
- Published
- 1994-04
- Volume
- 23
- Issue
- 4
- Pages
- 439-449
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2104598696
- Cited by
- 317
- References
- 36
- FWCI
- 14.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.